A randomised clinical trial to evaluate the effects of Plantago ovata husk in Parkinson patients: changes in levodopa pharmacokinetics and biochemical parameters

DSpace/Manakin Repository

A randomised clinical trial to evaluate the effects of Plantago ovata husk in Parkinson patients: changes in levodopa pharmacokinetics and biochemical parameters

Show full item record

Title: A randomised clinical trial to evaluate the effects of Plantago ovata husk in Parkinson patients: changes in levodopa pharmacokinetics and biochemical parameters
Author: Fernández, Nélida;Hernandez, Luis;Sierra, Matilde;Diez, M. José;Calle, Ángela P.;Carriedo, Demetrio;Sahagún, Ana M.;Anguera, Anna;García, Juan J.
xmlui.dri2xhtml.METS-1.0.item-contributor: Facultad de Veterinaria
xmlui.dri2xhtml.METS-1.0.item-area: Farmacologia
Abstract: Background: Plantago ovata husk therapy could be used in patients with Parkinson disease to reduce the symptoms of gastrointestinal disorders, but it is important to know whether this compound modifies levodopa pharmacokinetics. The maintenance of constant plasma concentrations of levodopa abolishes the clinical fluctuations in parkinsonian patients. The aim of this randomised clinical trial was to establish the influence of the fiber Plantago ovata husk in the pharmacokinetics of levodopa when administered to Parkinson patients well controlled by their oral medication. Methods: To evaluate the effects of this fiber on several biochemical parameters. 18 volunteers participated in the study and received alternatively two treatments (Plantago ovata husk or placebo) with their usual levodopa/carbidopa oral dose. On days 0 (initial situation), 14 and 35 of the study, blood samples were taken to assess levodopa pharmacokinetics and to determine biochemical parameters. Results: Levodopa Cmax was very similar in the initial situation (603.2 ng/ml) and after placebo administration (612.0 ng/ml), being slightly lower (547.8 ng/ml) when Plantago ovata husk was given. AUC was very similar in the three groups: initial situation.- 62.87 μg.min/ml, fiber treatment.- 64.47 μg.min/ml and placebo treatment.- 65.10 μg.min/ml. Fiber reduced significantly the number of peaks observed in the levodopa concentrations, maintaining concentrations more stable. No significant differences were found in total cholesterol, LDL-cholesterol and triglycerides with the administration of Plantago ovata husk. Conclusions: Plantago ovata husk administration caused a smoothing and homogenization of levodopa absorption, providing more stable concentrations and final higher levels, resulting in a great benefit for patients.
xmlui.dri2xhtml.METS-1.0.item-desfisica: P. 296-305
xmlui.dri2xhtml.METS-1.0.item-peerreviewed: SI
Publisher: Biomed central
xmlui.dri2xhtml.METS-1.0.item-citation: BMC complementary and alternative medicine, 2014, n. 14
URI: http://hdl.handle.net/10612/4705
Date: 2014-03-14
xmlui.dri2xhtml.METS-1.0.item-tipo: info:eu-repo/semantics/article
Subject: Ecología. Medio ambiente
Farmacología
Medicina. Salud
xmlui.dri2xhtml.METS-1.0.item-palclave: Levodopa
Parkinson patients
Pharmacokinetics
Biochemical parameters
Plantago ovata husk
Exportar referencia a Refworks:


Files in this item

Files Size Format View
BMC_Complem_Altern_Med_2014_14_296.pdf 1.298Mb PDF View/Open

This item appears in the following Collection(s)

Show full item record

Search DSpace


Advanced Search

Browse

My Account

Statistics